{"uri": "eng-9430096", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Zydus_Lifesciences", "type": "wiki", "score": 100, "label": {"eng": "Zydus Lifesciences"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 80, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Indian_rupee", "type": "wiki", "score": 70, "label": {"eng": "Indian rupee"}}, {"uri": "http://en.wikipedia.org/wiki/Special_economic_zone", "type": "wiki", "score": 41, "label": {"eng": "Special economic zone"}}, {"uri": "http://en.wikipedia.org/wiki/Bombay_Stock_Exchange", "type": "wiki", "score": 40, "label": {"eng": "Bombay Stock Exchange"}}], "eventDate": "2024-03-23", "totalArticleCount": 6, "title": {"eng": "Explained: Why Zydus Lifesciences shares hit record high today"}, "summary": {"eng": "Stock surged after US FDA's tentative approval for Letermovir tablets.\n\nShares of Zydus Lifesciences soared to a record high on Tuesday, after jumping sharply in early trade.\n\nZydus Lifesciences shares were up 2.02% at Rs 1,019.65 apiece on the Bombay Stock Exchange (BSE) at 2.22 pm.\n\nEarlier in the day, the company's shares rose to a record high of Rs 1,028.45.\n\nThe surge in stock value comes on the heels of the company receiving tentative approval from the US Food and Drug Administration (FDA) "}, "location": {"type": "place", "label": {"eng": "New Delhi"}, "country": {"type": "country", "label": {"eng": "India"}}}, "categories": [{"uri": "dmoz/Business/Opportunities/Networking-MLM", "label": "dmoz/Business/Opportunities/Networking-MLM", "wgt": 100}, {"uri": "dmoz/Shopping/Health/Substance_Abuse", "label": "dmoz/Shopping/Health/Substance Abuse", "wgt": 100}, {"uri": "dmoz/Business/Investing/Marketing_and_Advertising", "label": "dmoz/Business/Investing/Marketing and Advertising", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 93}], "articleCounts": {"eng": 6}, "sentiment": 0.2, "wgt": 448848000, "relevance": 1}